Fibrillex: Began Phase II/III study

Neurochem Inc. (TSE:NRM), Saint-Laurent, Quebec
Product: Fibrillex
Business: Metabolic, Renal
Therapeutic category: Matrix

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE